19.06.2018 - 21.06.2018Hilton Boston Woburn, 2 Forbes Road, Woburn 01801, USA
Time: 8:20 am to 5:15 pm
Conference themes The Scleroderma Drug Development Summit is industry's first networking and discussion forum dedicated to overcoming translational challenges in achieving disease modifying scleroderma therapeutics.
Professional congress organizer (PCO) Aarti Diwan
Notes Speakers: Marek Honczarenko (AbbVie), Jeffrey Siegel (Genentech), Gerald Horan (Celgene), Mark Tepper (Corbus Pharmaceuticals), Nicolas Wisniacki (GlaxoSmithKline)
